Restoring the Function of the Heart to Restore Hope
Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients find the disease has advanced and their options extremely limited.
Cardiac Dimensions’ mission is to give new hope to those suffering from heart failure so they can live longer, higher quality lives.
We’re harnessing our science, technology, and talent to take on this global crisis and improve the survivability for heart failure patients with FMR. Our goal is to treat patients earlier in the disease process—when it’s needed.
And by uniquely treating the underlying causes—not just symptoms.
We are a privately held company headquartered in Kirkland, Washington with operations in the United States, Australia, and Germany.
The Cardiac Dimensions team is comprised of seasoned veterans with more than 100 years of combined experience in complementary disciplines.
Cardiac Dimensions is backed by institutional investors with significant domain knowledge, deep industry relationships and a wide network of resources.
Join our mailing list for invitations to studies along with company announcements.
NOTE: The Carillon Mitral Contour System has received CE Mark (0344) and is available for sale in Europe and other countries that recognize CE Mark.
CAUTION: Investigational Device. Limited by United States law to investigational use.